Merit Medical Systems MMSI Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston ScientificBSX

-$30M-700%

TFX

TeleflexTFX

——

Other financials

Income statement

See full

Revenue$381.9M+7.5%

Gross profit$184.8M+7.4%

Operating income$44.2M+7.6%

Net income$41.0M+36.0%

EPS (diluted)$0.68+38.8%

Balance sheet

See full

Cash & equivalents$488.1M+23.4%

Total debt$821.6M+0.5%

Total equity$1.6B+13.9%

Total assets$2.7B+10.2%

Cash flow

See full

Operating cash flow$40.7M+0.3%

CapEx$16.0M-24.0%

Free cash flow$24.7M+26.5%

Valuation

See full

Market cap$4.01B-34.1%

Profitability

See full

Gross margin48.7%+0.9pp

Operating margin12.2%+0.6pp

Net margin9%+0.2pp

FCF margin14.3%+1.3pp

Returns & leverage

See full

Return on equity9.1%0.0pp

Debt / equity0.5×-0.1×

Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Merit Medical Systems's contingent consideration fair value adjustments?: Merit Medical Systems (MMSI) reported contingent consideration fair value adjustments of -$179K in Q1 2026.
How has Merit Medical Systems's contingent consideration fair value adjustments changed year-over-year?: Merit Medical Systems's contingent consideration fair value adjustments decreased by 117.5% year-over-year, from $1.02M to -$179K.